How do you know?

被引:5
作者
Rosenbaum, JT
Deodhar, A
Suhler, EB
Smith, JR
机构
[1] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA
关键词
D O I
10.1136/bjo.2004.042986
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:980 / 981
页数:2
相关论文
共 17 条
[1]  
Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944
[2]   Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. [J].
Beniaminovitz, A ;
Itescu, S ;
Lietz, K ;
Donovan, M ;
Burke, EM ;
Groff, BD ;
Edwards, N ;
Mancini, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09) :613-619
[3]   Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis -: An open, observational, extension study of a three-month, randomized, placebo-controlled trial [J].
Braun, J ;
Brandt, J ;
Listing, J ;
Zink, A ;
Alten, R ;
Burmester, G ;
Golder, W ;
Gromnica-Ihle, E ;
Kellner, H ;
Schneider, M ;
Sörensen, H ;
Zeidler, H ;
Reddig, J ;
Sieper, J .
ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2224-2233
[4]   EFFECTS OF ASPIRIN ON VITREOUS PRERETINAL HEMORRHAGE IN PATIENTS WITH DIABETES-MELLITUS - EARLY TREATMENT DIABETIC-RETINOPATHY STUDY REPORT NO-20 [J].
CHEW, EY ;
KLEIN, ML ;
MURPHY, RP ;
REMALEY, NA ;
FERRIS, FL .
ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (01) :52-55
[5]   AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS [J].
FELSON, DT ;
ANDERSON, JJ ;
BOERS, M ;
BOMBARDIER, C ;
FURST, D ;
GOLDSMITH, C ;
KATZ, LM ;
LIGHTFOOT, R ;
PAULUS, H ;
STRAND, V ;
TUGWELL, P ;
WEINBLATT, M ;
WILLIAMS, HJ ;
WOLFE, F ;
KIESZAK, S .
ARTHRITIS AND RHEUMATISM, 1995, 38 (06) :727-735
[6]  
FLEISHER LN, 1992, INVEST OPHTH VIS SCI, V33, P2120
[7]   Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate [J].
Foster, CS ;
Tufail, F ;
Waheed, NK ;
Chu, D ;
Miserocchi, E ;
Baltatzis, S ;
Vredeveld, CM .
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (04) :437-440
[8]   Natalizumab for active Crohn's disease. [J].
Ghosh, S ;
Goldin, E ;
Gordon, FH ;
Malchow, HA ;
Rask-Madsen, J ;
Rutgeerts, P ;
Vyhnalek, P ;
Zádorová, Z ;
Palmer, T ;
Donoghue, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :24-32
[9]  
Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714
[10]  
Hawkins BS, 2003, ARCH OPHTHALMOL-CHIC, V121, P1156